Dr Shreeya Taresh Indulkar

Dr. Shreeya Taresh Indulkar is an internationally trained Consultant Pathologist at Continental Hospitals, Gachibowli, Hyderabad, with subspecialty expertise in uro-oncopathology, molecular oncology, and digital pathology. With a strong academic and clinical foundation, she has been part of globally renowned institutions such as Johns Hopkins Medicine (USA) and MD Anderson Cancer Center (USA), contributing to translational cancer research and advanced diagnostics.

She completed her MBBS from Government Medical College, Akola, followed by MD Pathology from Seth GSMC & KEM Hospital, Mumbai, and DNB in Pathology (2016). She further pursued DipRCPath (UK) and FRCP Part 1 from the Royal College of Pathologists, UK. Her specialized training includes PDCC in Uro-Oncopathology at Basavatarakam Indo-American Cancer Hospital, Hyderabad, where she handled over 500 genitourinary cancer cases.

Dr. Shreeya’s clinical expertise spans genitourinary, gastrointestinal, and gynecological pathology, immunohistochemistry, molecular workflows, and biorepository QC. She has extensive experience in digital pathology (QuPath, HALO) and is an early adopter of AI applications in histopathology.

She has contributed to 10+ publications in indexed journals, including international platforms such as USCAP, AJSP, AIMM, and Surgical Pathology Clinics, and has presented at global conferences. She actively participates in multidisciplinary tumor boards, ensuring collaborative cancer care.

Dr. Shreeya is fluent in English, Hindi, and Marathi, and is recognized for her precision, evidence-based reporting, and commitment to advancing cancer diagnostics. At Continental Hospitals, she plays a key role in delivering accurate, patient-focused, and research-driven pathology services.

• MBBS
• MD (Pathology)
• DNB
• DipRCPath (UK)
• PDCC (Uro-Oncopathology)
• FRCP

• Uro-Oncopathology (Prostate, Kidney, Bladder Cancers)
• Translational Molecular Oncology
• Digital Pathology & AI Applications
• Gastrointestinal & Gynecological Pathology
• Immunohistochemistry & Molecular Workflows
• Tumor Board Reporting & Cancer Diagnostics

• Uro-Oncopathology Services – Expert reporting in prostate, kidney, and bladder cancers.
• Molecular Oncology Diagnostics – Stratification using IHC and molecular markers.
• Digital Pathology – Advanced slide analysis using QuPath, HALO & AI tools.
• Comprehensive Cancer Pathology – GU, GI, and GYN tumor diagnostics.
• Tumor Board Collaboration – Multidisciplinary review for precise cancer care.
• Biorepository & QC – High-quality tissue handling and research integration.

• Research Scientist at MD Anderson Cancer Center, USA (2024–2025).
• Research Fellow at Johns Hopkins Medicine, USA (2023–2024).
• Over 500 GU cancer cases reviewed during PDCC fellowship.
• 10+ indexed publications in international and national journals.
• Presented research at USCAP, AJSP, AIMM and other global conferences.